Point72 Asia (Singapore) Pte. Ltd. Caribou Biosciences, Inc. Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $532 Billion
- Q3 2024
A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 21 shares of CRBU stock, worth $46. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21
Previous 31,831
99.93%
Holding current value
$46
Previous $52.2 Million
99.92%
% of portfolio
0.0%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding CRBU
# of Institutions
135Shares Held
52.6MCall Options Held
148KPut Options Held
70.7K-
Black Rock Inc. New York, NY6.95MShares$15.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.62MShares$10.2 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC4.57MShares$10.1 Million0.0% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA4.31MShares$9.47 Million0.49% of portfolio
-
Kynam Capital Management, LP Princeton, NJ2.36MShares$5.18 Million0.38% of portfolio
About Caribou Biosciences, Inc.
- Ticker CRBU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,840,800
- Market Cap $134M
- Description
- Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...